featured
2021 Top Story in Rheumatology: Avacopan for ANCA-Associated Vasculitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Miloslavsky EM, Naden RP, Bijlsma JWJ, et al. Development of a glucocorticoid toxicity index (GTI) using multicriteria decision analysis. Ann Rheum Dis. 2017;76(3): 543-546.
- Stone JH, Merkel, PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221-232.
- Specks U, Merkel PA, Seo P, et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med. 2013;369(5):417-427.
- Jayne DRW, Merkel PA, Schall TJ, et al. Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med. 2021;384(7):599-609.
Disclosure statements are available on the authors' profiles: